FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BRENTUXIMAB VEDOTIN
异名/同义词ADCETRIS
BRENTUXIMAB [VANDF]
BRENTUXIMAB VEDOTIN
BRENTUXIMAB VEDOTIN (GENETICAL RECOMBINATION)
BRENTUXIMAB VEDOTIN [INN]
BRENTUXIMAB VEDOTIN [JAN]
BRENTUXIMAB VEDOTIN [MART.]
BRENTUXIMAB VEDOTIN [MI]
BRENTUXIMAB VEDOTIN [PURPLE BOOK CDER]
BRENTUXIMAB VEDOTIN [USAN]
BRENTUXIMAB VEDOTIN [VANDF]
BRENTUXIMAB VEDOTIN [WHO-DD]
CAC10-1006(4)
CAC10-VCMMAE
CAC10-VCMMAE(4)
CHIMERIC IGG1 CAC10 COVALENTLY LINKED TO THE CYTOTOXIC MOLECULE SGD-1010 VIA A PEPTIDE LINKER
MAB CHIMERIC (IGG1) ANTI P28908 (TNR8_HUMAN) (SGN-35)
SGN-35
CAS登记号914088-09-8
物质唯一标识(Unique Ingredient Identifier)7XL5ISS668
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System